New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
04:55 EDTACHC, ACHC, ACHC, BABY, BABY, BABY, CNC, CNC, CNC, INCY, INCY, INCY, AUXL, AUXL, AUXL, HGR, HGR, HGR, ALKS, ALKS, ALKS, ACHN, ACHN, ACHN, MZOR, MZOR, MZOR, LMNX, LMNX, LMNX, IDIX, IDIX, IDIXUBS to hold a conference
Global Healthcare Conference to be held in New York on May 19-21.
News For IDIX;LMNX;MZOR;ACHN;ALKS;HGR;AUXL;INCY;CNC;BABY;ACHC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 29, 2015
16:35 EDTAUXLEndo sees Auxilium transaction immediately accretive
Endo International plc (ENDP)announced it has completed the acquisition of Auxilium Pharmaceuticals (AUXL) in a transaction valued at $2.6B when announced on October 9, 2014. The closing of the transaction follows the approval of the acquisition by Auxilium's shareholders on January 27 and the receipt of all required regulatory approvals. Rajiv De Silva, president and CEO of Endo, stated, This strategic transaction enhances the organic growth of our branded pharmaceuticals business by adding a broad range of high quality products to our already robust portfolio and expanding our development pipeline. We are excited to deliver on the promise of this combination by leveraging our resources to enhance the performance of XIAFLEX and optimize TESTOPEL and STENDRA. We continue to expect the transaction to be immediately accretive for shareholders and meaningfully accretive each year moving forward. We believe that Endo is now even better positioned to drive growth across our product portfolio and to capitalize on additional future strategic M&A opportunities to create value for shareholders, customers and employees." Auxilium common stock will cease to be traded on the NASDAQ Global Market following the close of trading on January 29.
January 28, 2015
17:06 EDTINCYIncyte publish Phase III RESPONSE trial results for polycythemia vera patients
Subscribe for More Information
08:10 EDTINCYIncyte receives orphan status for pancreatic cancer treatment
Subscribe for More Information
07:08 EDTBABYNatus Medical raises FY15 EPS view to $1.42-$1.46 from $1.40-$1.44
Consensus $1.44. Raises FY15 revenue guidance to $373M-$375M from $367M-$369M, consensus $367.05M.
07:06 EDTBABYNatus Medical backs Q1 EPS view of 28c-30c, consensus 29c
Subscribe for More Information
07:05 EDTBABYNatus Medical reports Q4 EPS 40c, consensus 39c
Subscribe for More Information
06:19 EDTALKSAlkermes depression drug has significant upside potential, says Citigroup
Subscribe for More Information
January 27, 2015
09:35 EDTAUXLAuxilium shareholders approve merger with Endo
Subscribe for More Information
January 26, 2015
12:39 EDTCNCHHS Secretary orders Medicare to change payment method, WSJ says
Subscribe for More Information
07:05 EDTBABYNatus Medical acquires Global Neuro-Diagnostics
Natus Medical announced that it has entered the neurodiagnostic services market through the acquisition of Global Neuro-Diagnostics, or GND. GND was profitable in 2014 with revenue of approximately $7M. GND's service offers patients a more convenient way to complete routine video EEG testing which can be performed at the home, hospital or physician's office. The service also provides comprehensive reporting and support to the physician.
06:03 EDTCNCCentene to acquire Agate Resources
Centene announced that it has signed a definitive agreement to acquire Agate Resources, a diversified holding company that offers an array of healthcare products and services to Oregon residents. Agate is based in Eugene, Oregon. Trillium Community Health Plan, Inc., a subsidiary of Agate, participates in Oregon's Coordinated Care Organization model to provide Medicaid services to Oregon Health Plan members in Lane County, Oregon. Trillium also provides coverage to Medicare beneficiaries through a Medicare Advantage plan and participates on the Cover Oregon health insurance marketplace. Terry Coplin, the CEO of Agate, and the existing management team will continue to lead the local operations of Agate. The transaction is expected to close in Q3, subject to customary closing conditions, including Oregon regulatory approval. The deal is expected to be accretive to EPS in the first twelve months following close.
January 23, 2015
15:46 EDTLMNXPiper Jaffray's medtech analysts hold an analyst/industry conference call
Subscribe for More Information
12:52 EDTACHCJPMorgan reports 5.7% passive stake in Acadia
Subscribe for More Information
10:15 EDTACHNOptions with decreasing implied volatility
Subscribe for More Information
07:36 EDTINCYIncyte earns $25M milestone payment from Novartis for Jakavi
Subscribe for More Information
January 22, 2015
14:03 EDTAUXLAuxilium to host special shareholder meeting
Subscribe for More Information
10:35 EDTACHNOptions with decreasing implied volatility
Options with decreasing implied volatility: CZR ACHN NFLX SN NBR TLM CREE BBY LNCO BBRY
January 20, 2015
07:25 EDTHGRNoble Financial to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use